X

Month: June 2014

2014 06 23

R&D

Scandinavian Biopharma

Scandinavian Biopharma receives 4.5 MSEK in funding from Vinnova

Scandinavian Biopharma via its subsidiary ETVAX receives 4.5 MSEK in funding from Vinnova for its project “One world one vaccine – to prevent ETEC diarrhea”. Vaccination is one of the most effective and cost-effective medical interventions there are. Preventing disease if possible is something we all strive for. More than one million children under five […]

2014 06 19

Scandinavian Biopharma

Etvax® is now a registered trademark

Etvax® is now the registered trademark of Scandinavian Biopharma’s vaccine against diarrheal disease caused by enterotoxigenic E. coli bacteria (ETEC). Infections with ETEC bacteria are known to cause debilitating diarrhea in children living in endemic areas, and traveler’s diarrhea in travelers to such risk areas.  Etvax® is presently in Phase I/II clinical trials to document […]